Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Barry L. Pizer"'
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-11 (2018)
Abstract Background Neuroblastoma is a paediatric cancer that despite multimodal therapy still has a poor outcome for many patients with high risk tumours. Retinoic acid (RA) promotes differentiation of some neuroblastoma tumours and cell lines, and
Externí odkaz:
https://doaj.org/article/4abc4a9bb45b4dcea1ba1427833fc46f
Embryonal tumours account for 20% of paediatric central nervous system (CNS) tumours. Medulloblastoma (MB), the most frequent, arises in the cerebellum. Clinical strategies have been based on series of multi-institutional trials since the 1970s. Rece
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad6ff42a43a2ecddfe04b1de593173c3
https://doi.org/10.1093/med/9780199651870.003.0009
https://doi.org/10.1093/med/9780199651870.003.0009
Autor:
Neil D. Shaw, Chris Philpott, Dawn Leese, A.Martin Barrett, Barry L. Pizer, Kevin Windebank, J. Imeson
Publikováno v:
Journal of Pediatric Surgery. 39:1520-1523
Background The authors report the results of a prospective, multicenter, multidisciplinary study of central venous catheters (CVCs) in pediatric oncology patients analyzing factors involved in early failure. Methods Information was collected from par
Publikováno v:
Journal of Neurosurgery. 83:550-555
✓ Astroblastoma is a rare type of glial tumor, usually occurring in older children and young adults. It has a distinctive histological appearance that is characterized by a radiating arrangement of tumor cells that form perivascular pseudorosettes.
Publikováno v:
Mutation Research Letters. 347:135-139
The glycophorin A (GPA) mutation assay was used to examine the risk of in vivo somatic mutation in infants following neonatal administration of vitamin K. The assay assesses damage to erythroid stem cells by measuring the frequency of NO and NN varia
Autor:
Barry L. Pizer, John T. Kemshead
Publikováno v:
Leukemia & Lymphoma. 15:281-289
We describe the results of clinical studies investigating the role of monoclonal antibody (MoAb) targeted radiotherapy in the treatment of central nervous system (CNS) leukaemia. Seven children, aged 3-16 years, in second or subsequent meningeal rela
Publikováno v:
European Journal of Cancer. 28:511-513
INTRODUCTION MONOCLONAL ANTIBODIES (Mabs) clearly do not cross the blood-brain barrier when administered systemically. Consequently, their use as targeting agents within the central nervous system (CNS) is limited to situations where they are either
Autor:
Christopher L. Chandler, Varnavus Papanastassiou, K. Hopkins, Tony F. Zananiri, John T. Kemshead, Barry L. Pizer
Publikováno v:
International journal of radiation oncology, biology, physics. 31(3)
Purpose Treatment of malignant disease in the central nervous system (CNS) with systemic radiolabeled monoclonal antibodies (MoAbs) is compromised by poor penetration into the cerebrospinal fluid (CSF), limited diffusion into solid tumors, and the ge
Publikováno v:
International journal of radiation biology. 63(2)
Autor:
John T. Kemshead, Elizabeth Phimister, Adrian P. Gee, K. Patel, Barry L. Pizer, Tohro Sugimoto, Graham Frost, R. J. Rossell
Publikováno v:
Leukemia research. 16(3)
The Nalm-16 cell line was originally described as being of the null acute lymphoblastic leukaemia (ALL) phenotype. Using phenotypic and genotypic markers, we have demonstrated the line carries markers associated with cells of the B lineage. In additi